Ivan Tornos wants to transform Zimmer Biomet (NYSE: ZBH) into a fast-moving firm that better leverages tech in orthopedics. DeviceTalks Editorial Director Tom Salemi spoke with Tornos, chief operating officer of Zimmer Biomet, about the company’s broad technology offerings including its ZBEdge, Persona IQ smart knee implant and other digital data collectors. Tornos joined the […]
Penumbra beats The Street in Q3, grows sales 25%
Penumbra (NYSE:PEN) posted third-quarter results this week that beat the overall consensus on Wall Street. The Alameda, California-based company reported profits of $8.85 million, or 24¢ per share, on sales of $190.1 million for the three months ended Sept. 30, for a sales growth of 25.84% compared with Q3 2020. Get the full story on our […]
OrthoPediatrics reports mixed-bag results in Q3
OrthoPediatrics (NSDQ:KIDS) this week posted third-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. The Warsaw, Indiana-based orthopedics company reported losses of -$2.2 million, or -11¢ per share, on sales of $25.1 million for the three months ended Sept. 30, for a sales growth of 12.94% compared with Q3 2020. Adjusted […]
ICU Medical grows profits 24% in Q3 results
ICU Medical (NSDQ:ICUI) this week posted third-quarter results that beat the overall consensus on Wall Street. The San Clemente, California-based infusion therapy company reported profits of $31 million, or $1.43 per share, on sales of $336 million for the three months ended September 30, for a bottom-line gain of 24.4% on sales growth of 5.49% compared […]
Dentsply Sirona beats The Street in Q3 results
Dentsply Sirona (NSDQ:XRAY) posted third-quarter results this week that beat the overall consensus on Wall Street. The Charlotte, N.C.-based company reported profits of $103 million, or 47¢ per share, on sales of $1.07 billion for the three months ended September 30, for a bottom-line gain of 94.3% on sales growth of 19.44% compared with Q3 2020. […]
LivaNova skyrockets on Street-beating Q3 results
LivaNova (NSDQ:LIVN) today posted third-quarter results that beat the overall consensus on Wall Street. The London-based company reported losses of $42,000,000, or 82¢ per share, on sales of $253.2 million for the three months ended Sept. 30, for sales growth of 5.46% from Q3 2020. Adjusted to exclude one-time items, earnings per share were 68¢, 24¢ […]
Medtronic issues warning for some perfusion tubing packs
Medtronic has issued a warning letter regarding some of its Perfusion Tubing Packs. Friedly, Minnesota-based Medtronic’s urgent field safety notice informs users that some of its Perfusion Tubing Packs were manufactured without device-level testing for bacterial endotoxin, which is a necessary step to support non-pyrogenic label claim. The potential patient harms from endotoxin-mediated pyrogenicity include fever, […]
Boston Scientific recalls Hurricane RX biliary balloon dilation catheters
Boston Scientific has issued a warning letter recalling some of its Hurricane RX biliary balloon dilation catheters. Marlborough, Massachusetts-based Boston Scientific issued the recall because of complaints received for pinholes in the balloon. The balloon could rapidly lose pressure or fail to fail or maintain pressure due to the issue. Get the full story on our […]
Align Technology sales increase 38% in Q3
Align Technology (NSDQ:ALGN) posted third-quarter results that beat the overall consensus on Wall Street. The Tempe, Arizona-based Invisalign clear dental aligner maker yesterday evening reported profits of $180.9 million, or $2.28 per share, on sales of $1.01 billion for the three months ended September 30, for a bottom-line gain of 29.8% on sales growth of […]
Abiomed beats The Street in Q2, lowers full-year outlook
Abiomed (NSDQ:ABMD) posted second-quarter results this week that beat the overall consensus on Wall Street. The Danvers, Massachusetts-based cardiovascular device company reported profits of $56.95 million, or $1.24 per share, on sales of $248.1 million for the three months ended September 30, for a bottom-line loss of -8.5% on sales growth of 18.3% compared with Q2 […]
Baxter beats EPS consensus, matches revenue estimates in Q3
Baxter (NYSE:BAX) today posted third-quarter results that beat the overall consensus on Wall Street. The Deerfield, Illinois-based company reported profits of $452 million, or 89¢ per share, on sales of $3.23 billion for the three months ended September 30, for a bottom-line gain of 25.9% on sales growth of 8.55% compared with Q3 2020. Adjusted to […]